WASATCH ADVISORS LP 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 5:10 pm Sale | 2024-02-09 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 850,308 4.900% | -150,253 (-15.02%) | Filing |
| 2023-02-09 5:03 pm Sale | 2023-02-09 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 1,000,561 6.100% | -105,199 (-9.51%) | Filing |
| 2022-02-11 2:09 pm Sale | 2022-02-11 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 1,105,760 6.800% | -585,747 (-34.63%) | Filing |
| 2021-04-09 2:00 pm Purchase | 2021-04-09 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 1,691,507 10.000% | 647,104 (+61.96%) | Filing |
| 2021-02-11 2:47 pm Purchase | 2021-02-11 | 13G | Exagen Inc. XGN | WASATCH ADVISORS LP | 1,044,403 8.300% | 1,044,403 (New Position) | Filing |